Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

Recruiting Observational Study
Opioid-Induced Esophageal Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
26 (estimated)
Sponsor
Mayo Clinic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms. Exclusion Criteria: * Inability to provide informed consent. * Patients with previous gastroesophageal surgery or pneumatic dilation. * Esophageal botulinum toxin …
Contacts

Mariah Robran

507-266-3595

robran.mariah@mayo.edu

CONTACT